Related by context. All words. (Click for frequent words.) 73 Chronic Heart Failure 73 Severe Sepsis 72 Decompensated Heart Failure 72 Coronary Artery Bypass Graft 72 Ischemic Stroke 71 Acute Ischemic Stroke 71 Refractory Angina 71 Acute Heart Failure 70 Acute Myocardial Infarction 70 Stent Thrombosis 70 ADHERE 70 Prospective Randomized 70 Valvular Heart Disease 70 Patient Outcomes 70 ST Segment Elevation 70 Pulmonary Arterial Hypertension 70 STRIDE PD 69 Pivotal Phase III 69 Hedgehog Pathway Inhibitor 69 Advanced Heart Failure 69 Diabetic Foot Ulcer 69 Acute Coronary Syndromes 69 Liver Failure 69 Oral Fingolimod 69 Thrombolysis 69 Investigational Treatment 69 Bucindolol 69 Pivotal Trial 69 Carotid Stenting 69 Prospective Multicenter 69 Ischemic 69 Intracerebral Hemorrhage 68 Heart Failure Patients 68 ST Elevation Myocardial 68 Phase 2b Clinical Trial 68 Current Controlled Trials 68 Patient Registry 68 Patients Receiving 68 Fabry Disease 68 Cardiotoxicity 68 Aneurysm Repair 68 Infarct 68 metastatic malignant 68 Val HeFT 68 Randomized Evaluation 68 II Clinical Trial 68 Myocardial Infarction 68 Carotid Endarterectomy 68 Phase 2b Study 68 Schizophrenia Treatment 68 Unstable Angina 68 Meets Primary Endpoint 68 Randomized Clinical Trial 68 See CLINICAL PHARMACOLOGY 68 Orthostatic Hypotension 68 Demonstrates Positive 68 Relapsing Multiple Sclerosis 68 Phase III Clinical Trial 68 Chronic Sinusitis 68 either acutely decompensated 68 Lung Injury 68 Advanced Melanoma 68 Circulatory Support 68 Myoblast 68 Fungal Infections 68 Peripheral Arterial 68 Clinical Outcome 68 Hospitalized Patients 68 Angiographic 68 treatment naive genotype 68 USpella 67 Phase Ib Clinical Trial 67 Myocardial Ischemia 67 Decitabine 67 LUMINATE 67 Randomized Study 67 Nesiritide 67 CHAMPION PCI 67 Heterozygous Familial Hypercholesterolemia 67 Patients Treated With 67 Left Ventricular Dysfunction 67 Aortic Dissection 67 Edge STudy 67 Prolongs Survival 67 Subgroup Analysis 67 recurrent malignant glioma 67 Phase 2a Clinical Trial 67 FDA Approvals 67 unfractionated heparin UFH 67 Enzyme Replacement Therapy 67 Hypotension 67 Systemic Lupus Erythematosus SLE 67 Urocortin 2 67 Improves Outcomes 67 Acute Coronary Syndromes ACS 67 Risk Stratification 67 Relapsing Remitting Multiple Sclerosis 67 Combination Treatment 67 Carotid Revascularization Endarterectomy vs. 67 Congestive Heart Failure 67 Zenvia Phase III 67 Juvenile Idiopathic Arthritis 67 Degarelix 67 Sapacitabine 67 Clinical Trial Results 67 Renal Cancer 67 Pivotal Clinical Trial 67 Nebulized 67 Left Ventricular 67 Antiplatelet Therapy 67 Secondary Hyperparathyroidism 67 ABSORB trial 67 Cardiovascular Outcomes 67 multicentre prospective 67 MEND CABG 67 Etanercept 67 Systemic Sclerosis 67 Critical Limb Ischemia CLI 67 Soft Tissue Sarcoma 67 Hemorrhagic Stroke 67 Atypical Hemolytic Uremic Syndrome 67 Long Term Efficacy 67 Percutaneous Coronary Intervention 67 Catheter Associated 67 Cardiac Resynchronization Therapy 67 Heart Transplant Recipients 67 Eculizumab 67 relapsed MM 67 Study Evaluating 67 Ranolazine 66 Hepatocellular Carcinoma 66 Clinical Trial Data 66 Valvular 66 number NCT# ClinicalTrials.gov 66 Pegylated Liposomal Doxorubicin 66 Pooled Analysis 66 Iron Overload 66 EVEREST II 66 Venous Thromboembolism 66 Acute Stroke 66 transcranial Doppler ultrasound 66 Bronchiectasis 66 Renal Impairment 66 Phase IIb Clinical Trial 66 Myocardial Infarction Study 66 multicenter randomized controlled 66 Pivotal Study 66 Phase 2a Trial 66 Clinical Trial Evaluating 66 atypical Hemolytic Uremic Syndrome 66 Intracranial Aneurysms 66 Safinamide 66 REVEAL Registry 66 biliary tract cancer 66 Severe Asthma 66 Hemodialysis Patients 66 Renal Artery 66 Lupus Nephritis 66 Acute Renal Failure 66 ATACAND 66 Outpatient Setting 66 Adjunctive 66 Laryngeal Cancer 66 Initiates Phase III 66 Fondaparinux 66 Afib 66 Ischaemic 66 Lung Cancer Trial 66 Glatiramer Acetate 66 Phase IIb Trial 66 Patients Undergoing 66 CIMZIA TM certolizumab pegol 66 Multicenter 66 RE LY ® 66 Novel Oral 66 Multiple Ascending Dose 66 icatibant 66 First Patient Enrolled 66 Metastatic Melanoma 66 multicenter prospective 66 Tyrosine Kinase Inhibitor 66 Phase Ib II 66 Sipuleucel T 66 Overactive Bladder 66 randomized multicenter trial 66 Hypercholesterolemia 66 Chronic Renal Failure 66 Investigational Drug 66 Relapsed Multiple Myeloma 66 ENDEAVOR IV 66 Aortic Valve Replacement 66 Improve Survival 66 Renal Function 66 JAK2 Inhibitor 66 Bronchial Thermoplasty 66 National Oncologic PET 66 Antitumor Activity 66 INTEGRILIN R 66 undergoing elective percutaneous 66 Diastolic Heart Failure 66 Mycophenolate Mofetil 66 Dual Antiplatelet Therapy 66 Interventional Procedures 66 catheter occlusion 66 CARE HF 66 Phase III Trial 66 Patency 66 Diabetic Nephropathy 66 dose escalation phase 66 Phase 2b Trial 66 unstable angina pectoris 66 Diabetic Neuropathy 66 Tumor Response 66 Reduces Mortality 66 Chronic Myeloid Leukemia 66 Newly Diagnosed Multiple Myeloma 66 BRIM2 66 patientswith 66 Renal Cell Carcinoma RCC 66 ZACTIMA 66 Carotid 66 Acute Liver Failure 66 Feasibility Trial 66 fosbretabulin 66 Echocardiographic 65 Trandolapril 65 Initiates Enrollment 65 ENESTnd 65 MGd 65 Rheumatoid Arthritis Patients 65 dual endothelin receptor antagonist 65 Sleep Disturbances 65 Carotid Artery Stenting 65 NSABP B 65 keloid scarring 65 Intervention Effectiveness 65 Phase III Pivotal 65 Hsp# Inhibitor 65 Myocardial 65 Aortic Stenosis 65 Anticoagulant 65 Anticoagulation 65 Granted Orphan Drug 65 allogeneic hematopoietic cell 65 Completes Patient Enrollment 65 EchoCRT 65 Arch Neurol 65 Treated Patients 65 Myelodysplastic Syndrome 65 REMINYL ® 65 Disease Progression 65 Non Alcoholic Steatohepatitis 65 HCV Protease Inhibitor 65 Initiates Clinical Trial 65 Dose Ranging Study 65 Intravascular 65 Phase Ib clinical 65 AFREZZA TM 65 Phase IIIb 65 Phase IIa Clinical Trial 65 Randomized Double Blind 65 phase IIa clinical 65 Renal Transplantation 65 Tipranavir 65 Nymox NX 65 Adjunctive Therapy 65 Beta Blocker 65 Confirmatory Phase 65 ACC NCDR 65 Subarachnoid hemorrhage 65 Allogeneic 65 Stent Restenosis 65 STENT 65 Diabetic Macular Edema 65 Breast Cancer Recurrence 65 Preclinical Models 65 Tanespimycin 65 ACE Inhibitor 65 Thrombotic 65 Non inferiority 65 paroxysmal nocturnal hemoglobinuria 65 Septic Shock 65 Inhaled Nitric Oxide 65 Bacteremia 65 Patient Enrollment 65 ORENCIA ® 65 cytomegalovirus infection 65 Cardiac Resynchronization 65 Catheter Ablation 65 Clinical Evaluation 65 Plaque Psoriasis 65 Candesartan 65 Bivalirudin 65 Chemoradiation 65 Uterine Fibroid Embolization 65 Biomarker Study 65 PICSO ® 65 Coronary Revascularization 65 Bloodstream Infections 65 Treating Chronic 65 J Am Acad 65 Coronary Angiography 65 Artery Disease 65 multicenter multinational 65 Acute Coronary Syndrome 65 CIMZIA ™ 65 NDA Submission 65 Is Well Tolerated 65 chronic myocardial ischemia 65 Dupuytren Contracture 65 ACE Inhibitors 65 IND Filing 65 Double Blind Randomized 65 Demonstrates Efficacy 65 recurrent glioma 65 Non Alcoholic Fatty 65 Respiratory Distress 65 ICAEL 65 terlipressin 65 Recurrent Glioblastoma 65 placebo controlled clinical 65 Follicular Lymphoma 65 Controlled Study 65 Hemophilia B 65 Topline Results 65 prospective multicentre 65 CYT# potent vascular disrupting 65 metastatic neuroendocrine tumors 65 Randomized Controlled Trials 65 complement inhibitor eculizumab 65 Dilated Cardiomyopathy 65 Myelodysplastic Syndromes 65 Hyperlipidemia 65 Pemphigus 65 ENDEAVOR II 65 J Am Coll 65 Catena ® 65 Randomized Phase II 65 Arrhythmogenic 65 Surgical Treatment 65 JAK Inhibitor 65 Natalizumab 65 prospective nonrandomized 65 prospective multicenter study 65 Treatment Outcome 65 Occlusive Disease 65 LEUKINE 65 Antiviral Therapy 65 Registry NOPR 65 MAGE A3 ASCI 65 Unfractionated Heparin 65 Metastatic Renal Cell Carcinoma 65 Randomised 65 Renal Cell Carcinoma 65 candesartan cilexetil 65 Treatment Resistant 65 Prophylactic Treatment 65 Immunosuppression 65 Shows Efficacy 65 Nonalcoholic Fatty Liver Disease 65 Double Blind Placebo 65 failure ADHF 65 Shows Promise Against 65 chronic eosinophilic leukemia 65 myocardial infarction ventricular fibrillation 64 Abciximab 64 Hormone Refractory Prostate Cancer 64 HORIZONS AMI 64 Differential Diagnosis 64 Nilotinib 64 Adult Stem Cell Therapy 64 Pafuramidine 64 Drug Eluting Coronary Stent 64 Randomized Double blind 64 Non Invasive Treatment 64 Insulin Therapy 64 ARIXTRA R 64 Paroxysmal Atrial Fibrillation 64 NAVISTAR R 64 TAXUS TM 64 Hospital Acquired Pneumonia 64 Pyridorin 64 Complicated Skin 64 Predict Risk 64 Parenteral Nutrition 64 Controlled Trial 64 Improved Survival 64 Cutaneous T 64 prospective multicenter 64 HeFH 64 Gastric Cancer 64 Appears Safe 64 Hepatotoxicity 64 Symptom Relief 64 AA Amyloidosis 64 Efficacy Trial 64 Chronic Lymphocytic Leukemia 64 Preclinical Study 64 Vascular Ultrasound 64 Golimumab 64 Resistant Hypertension 64 Pharmacokinetic Study 64 Hyperkalemia 64 Low Incidence 64 refractory chronic lymphocytic 64 Angioedema 64 Renal Failure 64 CAMMS# 64 Successfully Completes Phase 64 Percutaneous Tibial Nerve Stimulation 64 Chronic Insomnia 64 CALGB # [002] 64 Bosutinib 64 Novel Compound 64 XIENCE V PROMUS Stent 64 Pivotal Phase 64 Transcatheter 64 NYHA Class II 64 Electroencephalography 64 Phase IIIb study 64 Hematopoietic Stem Cell Transplantation 64 Ambulatory Blood Pressure 64 allogeneic hematopoietic stem cell 64 BR.# 64 Multicenter Randomized Double 64 Teva Provides Update 64 Balloon Angioplasty 64 Rheos System 64 Critically Ill Patients 64 Improves Survival 64 AIR2 Trial 64 Dose Finding 64 Enzastaurin 64 overactive bladder syndrome 64 Anti Tumor Activity 64 cinacalcet 64 Sustained Reduction 64 Malignant Melanoma 64 Epratuzumab 64 CLARITY TIMI 64 Hepatocellular Carcinoma HCC 64 Corneal Transplant 64 GAMMAGARD 64 Cardiometabolic 64 Heart Failure Treatment 64 sitaxsentan 64 Ischemia 64 Intravitreal 64 BARACLUDE ® 64 randomized controlled multicenter 64 rFVIIa 64 blinded randomized placebo controlled 64 Endarterectomy 64 Adverse Event 64 MR Angiography 64 colesevelam HCl 64 Malignant Glioma 64 Sustained Efficacy 64 Embolization 64 Dose Escalation 64 Breast Ultrasound 64 Anti Bacterial Envelope 64 Community Acquired Pneumonia 64 Coronary Artery Bypass Grafting 64 Slow Progression 64 Glypromate 64 randomized Phase IIb 64 Nicotine Vaccine 64 myelodysplastic myeloproliferative diseases 64 Diabetic Patients 64 Castration Resistant Prostate Cancer 64 invasive aspergillosis 64 IMPACT DCM clinical 64 PROMUS R 64 relapsing multiple sclerosis 64 Ventricular Tachycardia 64 Endovascular Treatment 64 ANN INTERN MED 64 Antiplatelet 64 Interagency Registry 64 Demonstrates Sustained 64 Covered Stent 64 Initiate Phase 64 Completes Enrollment 64 Decompensated 64 Drug Eluting Stent System 64 recurrent glioblastoma multiforme 64 ECASS 64 Liver Metastases 64 RE LY 64 Cognitive Impairment 64 chronic thromboembolic pulmonary 64 atrioventricular block 64 Related Mortality 64 Elderly Patients 64 TAXUS ATLAS 64 Bepreve TM 64 Chronic Bronchitis 64 Rilonacept 64 First Patient Treated 64 Peptic Ulcer 64 clevidipine 64 Denufosol 64 Myocardial Perfusion Imaging 64 Accelerated Partial Breast Irradiation 64 Omacetaxine 64 hyperphenylalaninemia HPA due 64 Warfarin Coumadin 64 HeartMate R 64 OMNARIS HFA 64 phase IIb trial 64 Arch Intern Med 64 undergoing Percutaneous Coronary 64 Antiepileptic Drug 64 Initiates Clinical 64 evaluating mipomersen 64 Patients Treated 64 Aggressive Reduction 64 Xelox 64 Asthma COPD 64 acute humoral rejection 64 HBeAg + 64 Brain Metastases 64 Investigational Compound 64 Valve Replacement 64 Inflammatory Markers 64 Venous Thrombosis 64 unstable angina UA 64 Treatment Naive Patients 64 moderate hepatic impairment 64 Solid Tumors 64 Unresectable 64 EURIDIS 64 Deferiprone 64 MEND CABG II 64 MADIT II 64 Sleep Disordered Breathing 64 Intravesical 64 cardiac resynchronisation therapy 64 morphometric vertebral fractures 64 Left Atrial 64 Chronic Hepatitis C 64 Critical Limb Ischemia 64 prospective multicenter randomized 64 riociguat 64 noninfectious uveitis 64 GATTEX TM 64 Pediatric Patients 64 Radiofrequency Ablation 64 Romiplostim 64 Atherothrombosis 64 prospective observational 64 LUX Lung 64 registrational Phase 64 Bare Metal Stent 64 Clinical Efficacy 64 Endovascular Repair 64 Metastatic Prostate Cancer 63 Antithrombin 63 Pneumococcal Vaccine 63 Relapsed Refractory 63 Paroxysmal Nocturnal Hemoglobinuria 63 decompensated heart failure 63 Kidney Transplant Patients 63 Randomized Clinical Trials 63 Inhaled Corticosteroids 63 GOUT 63 Stem Cell Treatment 63 Initiated Phase 63 Hematological 63 Knee Osteoarthritis 63 Hydroxyurea 63 Initiate Clinical Trial 63 Infarction 63 Ceflatonin R 63 Cell Lymphoma 63 Thromboembolism 63 Contrast Enhanced 63 #-# Full Text 63 Renal Anemia 63 Delcath Phase III 63 Adjuvant Treatment 63 Moxifloxacin 63 venous thromboembolic disease 63 Major Depressive Disorder 63 Percutaneous Transluminal Coronary Angioplasty 63 G CSFs 63 Endometrial Cancer 63 Drug Prevents 63 Multicenter Study 63 atherothrombotic disease 63 Deforolimus 63 Drug Eluting Stents 63 prospective randomized multicenter 63 Combination REOLYSIN R 63 Immunodeficiency 63 Phase #b/#a clinical 63 macular edema secondary 63 Recurrent Breast Cancer 63 Transplant Patients 63 FDA APPROVES 63 Hemolysis 63 Angiox ® 63 CT Angiography 63 CALGB 63 Cardiac Stem Cell 63 Major Depressive Disorder MDD 63 Adjuvant Chemotherapy 63 HoFH 63 Endothelial Dysfunction 63 LANTUS ® 63 Multicenter Trial 63 Meta Analysis 63 Delayed Graft Function 63 hypereosinophilic syndrome 63 Therapeutic Efficacy 63 GATTEX ™ 63 intravesical infusion therapy 63 pretransplant 63 Arteriovenous 63 PAOD 63 ARIXTRA 63 Tigecycline 63 acute decompensated heart 63 Intracerebral 63 Implantable Cardioverter Defibrillator 63 Tolvaptan 63 FOLOTYN ® 63 multicentre randomized 63 DEB# 63 Chronic Wounds 63 Naive Patients 63 Benign Prostatic Hyperplasia 63 Microalbuminuria 63 Long Lesion 63 Hepatitis C HCV 63 Post Operative 63 FASEB J. 63 SPRYCEL ® 63 MMR Vaccine 63 somatostatin analog 63 Hip Fracture 63 Placebo Controlled Study 63 Minimally Invasive Treatment 63 Stent Placement 63 Acute Myocardial 63 Prostate Cancer Patients 63 ONTARGET 63 Effectively Treats 63 J Clin 63 Proc Am Soc 63 Neonates 63 Treatment Reduces 63 non valvular atrial 63 HER2 Positive Breast Cancer 63 Treating Heart Failure 63 abacavir Ziagen 63 Invasive Breast Cancer 63 Systemic Lupus Erythematosus 63 Lenalidomide 63 Phase 1b Clinical Trial 63 Vascular Disease 63 vapreotide acetate 63 Stanate R 63 Pemetrexed 63 Febuxostat 63 Protease Inhibitor 63 Treating Depression 63 ADHF 63 Cinacalcet HCl 63 Ozarelix 63 Phase #/#a 63 RE MODEL 63 Preclinical Data 63 Lymphocytic 63 transplantation HSCT 63 CentriMag 63 symptomatic intracranial 63 descending thoracic 63 Hemodynamic 63 achieved CCyR 63 TM Everolimus Eluting 63 induce orthostatic hypotension 63 Phase III HEAT 63 Rotavirus Vaccine 63 Acute Myocardial Infarction AMI 63 Tiotropium 63 BENICAR HCT 63 acutely decompensated heart 63 Valsartan 63 Ventricular Arrhythmias 63 Pharmacodynamics 63 longitudinal cohort study 63 Prostate Cancer Treatment 63 Guidelines Issued 63 gefitinib Iressa 63 Pegloticase 63 Arterial Disease 63 Platelet Inhibition 63 Systolic Hypertension 63 EnteroMedics proprietary neuroblocking technology 63 Neoadjuvant 63 BrachySil TM 63 Parathyroid Hormone 63 J Clin Endocrinol Metab 63 ImmuKnow R 63 NCIC CTG 63 HCV Genotype 63 Atomoxetine 63 including eniluracil ADH 63 Arch Facial Plast 63 Metabolic Disorder 63 intravascular hemolysis 63 Simulect 63 Female Urology 63 Clinical Outcomes 63 Paroxysmal 63 haematologic 63 Phase III Psoriasis 63 PRADAXA 63 Reduced Risk 63 Infusion Reactions Severe 63 Initiates Phase II 63 DAPT 63 TMS Therapy 63 Primary Hypercholesterolemia 63 Immunomedics Announces 63 clazosentan 63 TG MV 63 Novel Inhibitor 63 Metabolic Disease 63 Demonstrates Significant 63 Oral Spray 63 Survival Benefit 63 Thiazolidinediones 63 adalimumab Humira 63 SHPT 63 AFRS TM 63 EXPLORE Xa 63 Hepatic 63 Hormone Receptor Positive 63 Coronary CTA 63 Localized Prostate Cancer 63 Phase IIB 63 Renal dysfunction 63 ExTRACT TIMI 63 Chronic Rhinosinusitis 63 Premature Infants 63 Intravenous Formulation 63 phase IIIb 63 Triapine R 63 Guideline Update 63 kidney urologic 63 Nonalcoholic Steatohepatitis 63 EECP R 63 Single Dose 63 Mipomersen 63 Transdermal Patch 63 Microwave Ablation System 63 Diabetic Retinopathy 63 Cypher Sirolimus 63 Coronary Intervention 63 Treatment Regimen 63 severe hypercholesterolemia 63 Initiate Phase II 63 Eur J 63 mechanically ventilated patients 63 Phase III Clinical Trials 63 Peritoneal Dialysis 63 Antiangiogenic 63 heparin induced thrombocytopenia 63 IMPACT DCM 63 Phase 1a clinical 63 Embolic Protection Device 63 J Shoulder Elbow 63 Proves Effective 63 hepatorenal syndrome 63 ARCOXIA 63 allogeneic bone marrow 63 Platinol ® 63 DUROS 63 Antihypertensive 63 placebo controlled Phase III 63 retrospective observational study 63 paroxysmal atrial fibrillation 63 Well Tolerated 63 Hepatic Encephalopathy 63 Clostridium difficile Infection 63 Randomized Phase 63 Acute Radiation Syndrome ARS 63 J Foot Ankle 63 Statin Therapy 63 Neuroendocrine Tumors 63 atherosclerotic renal artery stenosis 63 vWD 63 Randomized controlled 63 HORIZONS AMI trial 63 Aortic Valve 63 Skin Lesions 63 Therapy Improves 63 briakinumab 63 brivaracetam 63 Respiratory Virus 63 Randomized Comparison 63 IL# PE#QQR 63 Chronic Hepatitis B 63 Pharmacokinetics PK 63 Randomized Controlled 63 BRIM3 63 invasive candidiasis 63 TM Drug Eluting 63 Drug Shows Promise 63 Clinical Documentation 63 Betaferon R 63 Patient Enrolment 63 Known hypersensitivity 63 Pivotal Trials 63 landmark ATHENA trial 63 Randomized Phase III 63 Mg Usa 63 multicenter Phase III 63 Cardiac Allograft Rejection 63 psoriatic arthritis PsA 63 Tocilizumab 63 Exacerbation 63 Daclizumab 62 Embolic Protection 62 Autoimmune Disease 62 MERLIN TIMI 62 Elagolix 62 Vascugel ® 62 Recurrent Prostate Cancer 62 Morquio 62 Chronic Lymphocytic Leukemia CLL 62 Hematological Malignancies 62 ZOLINZA 62 CLARITY study 62 PEG IFN 62 Androxal TM 62 Ropinirole 62 Hypertrophy 62 ATIR 62 Bipolar Mania 62 Demonstrate Significant 62 galiximab 62 Vimpat R 62 REMINDER ORLive Presents 62 Platinum Chromium Coronary Stent 62 novel VDA molecule 62 Vascugel 62 Prognostic Significance 62 amalgam fillings mercury vapor 62 HIV HCV coinfected 62 Bipolar Disorders 62 dilated cardiomyopathy DCM 62 CABG Surgery 62 Vicriviroc 62 QuadraSphere 62 MRSA Infections 62 Diabetic Kidney Disease 62 Leukemias 62 de novo kidney transplant 62 Dacogen decitabine 62 HuMax 62 Aflibercept 62 beta 1a 62 Intra Arterial 62 NATRECOR ® 62 ® pioglitazone HCl 62 GRNCM1 62 thorough QT 62 RNAi Therapeutic 62 Phase Ib IIa 62 vinorelbine tartrate 62 Postmarketing 62 Intra operative 62 Abstract Accepted 62 Desvenlafaxine Succinate 62 Crit Rev 62 PFO migraine 62 percutaneous transluminal coronary angioplasty 62 Total Hip Arthroplasty 62 Estrogen Receptor 62 Peginterferon 62 Vascular Grafts 62 Cethromycin 62 smoldering multiple myeloma 62 Severe VOD 62 Phase IIIb clinical 62 Ribavirin causes 62 Radiofrequency Ablation RFA 62 Replacement Therapy 62 antiarrhythmic drug 62 MEK Inhibitor 62 Hypertriglyceridemia 62 Atacand ® 62 multicenter randomized clinical 62 Atopic Dermatitis 62 Lymphoid 62 OLYMPIA registry 62 Kidney Function 62 argatroban 62 PEGINTRON TM 62 Matrix Phase 2b 62 Initiates Phase 2b 62 NMIBC 62 APEX PD 62 mild renal insufficiency 62 Nocturia 62 Coherex FlatStent 62 CIPN 62 Mouse Model 62 Chronic Myelogenous Leukemia 62 PI3K/Akt pathway inhibitor 62 Autologous Stem Cell Transplantation 62 biologic DMARD 62 Multicenter Randomized 62 Newly Diagnosed 62 Myelofibrosis 62 Oral Calcitonin 62 INCB# [003] 62 Neoadjuvant Chemotherapy 62 hemodynamically significant 62 Immunosuppressant 62 Abdominal Pain 62 Thrombus 62 HCV SPRINT 62 Drug Candidate 62 Advanced Renal Cell 62 Diabetic Neuropathic Pain 62 TAXUS ARRIVE 62 Antitumor 62 personalized cellular immunotherapy 62 Severe Chronic Neutropenia 62 phase IIb clinical 62 LHRH receptor positive 62 diabetes mellitus DM 62 carotid endarterectomy CEA 62 R lenalidomide 62 EXJADE 62 Prognostic Value 62 evaluating tivozanib 62 Skeletal Muscle 62 MTWA testing 62 Heart Failure 62 Adenomas 62 Treatment Naïve 62 CIMZIA R 62 functional mitral regurgitation 62 Lung Cancer Survival 62 Eluting Stent 62 ACTEMRA TM 62 Total Knee Arthroplasty 62 Myelodysplastic Syndrome MDS 62 Neovascular Age Related Macular 62 nicardipine 62 Advanced Colorectal Cancer 62 Cholesterol Levels SPARCL 62 Teriparatide 62 serum phosphorous 62 Antigen Specific 62 Vertebral Fractures 62 preserved ejection fraction 62 chronic immune thrombocytopenic 62 Stenting 62 randomized multicenter Phase III 62 Vulnerable Plaque 62 investigational pharmacologically unique 62 Generalized Anxiety Disorder 62 Chronic Constipation 62 Presents Positive 62 Erythropoiesis Stimulating Agents ESAs 62 Bone Metastases 62 Metabolic Efficiency 62 Combo Therapy 62 AVAPRO 62 Initiate Lifesaving Treatment 62 NASH Huntington 62 familial amyloidotic polyneuropathy FAP 62 Dyloject TM 62 MIVI TRUST 62 Neuroendocrine Tumor 62 Angiox R 62 histologically confirmed 62 Neurologic Disorders 62 PROTECT AF 62 Bioequivalence 62 eosinophilic asthma 62 Zolpimist ™ 62 phase IIa 62 Pivotal Phase II 62 Aeolus Pharmaceuticals Announces 62 Lubiprostone 62 Hepatitis C Genotype 62 Interferon Beta 62 Rheumatoid 62 Patients Suffering 62 Neurogenic 62 Cognitive Function